Medesthetic Center Chosen to Receive the First Limited Shipment of Merz Aesthetics New Botulinum Toxic, Xeomin!

The Medesthetic Center, Beaumont’s premier destination for the most advanced skin and laser treatments, will be among the first aesthetic offices in the United States to receive Xeomin for cosmetic use beginning November 1st, 2011, at discounted prices.

FDA Approves Xeomin for temporary improvement to frown lines between the brows

Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.